H7N9 Bird Flu Virus - Biotech, Pharma and Life Science Channel

20:24 EDT 20th August 2014 | BioPortfolio

Avian influenza A H7 viruses are a group of influenza viruses that normally circulate among birds. The avian influenza A(H7N9) virus is one subgroup among the larger group of H7 viruses. Although some H7 viruses (H7N2, H7N3 and H7N7) have occasionally been found to infect humans, no human infections with H7N9 viruses have been reported until recent reports from China.

News Articles [7 Associated News Articles listed on BioPortfolio]

Pandemic Influenza - Pipeline Review, H2 2014

Recently added to the BioPortfolio report store, Pandemic Influenza - Pipeline Review, H2 2014 is a new report from Global Markets Direct published on 2014-07-30. This 146-page report is available in...

NAS911 Being Evaluated as Co-Therapeutic for Treatment of Influenza

SCOTTSDALE, AZ -- (Marketwired) -- 08/06/14 -- New Amsterdam Sciences (NAS), an emerging bioscience company focused on treating respiratory illnesses, announced today the completion of initial confir...

InDevR Awarded $2.9 M to Advance Titer on Chip(R) for Pandemic Flu Vaccines

BOULDER, CO--(Marketwired - July 22, 2014) - InDevR, a Boulder-based life science company, announced today that it has received an SBIR Phase II grant from the National Institute of Allergy and Infect...

Arbor Vita Corporation's A/H7N9 Influenza Rapid Detection Test Authorized for Emergency Use by FDA

FREMONT, Calif., April 30, 2014 /PRNewswire-iReach/ -- A new strain of the avian influenza virus appeared in China in 2013.  This particular 'bird flu', influenza A/H7N9 virus (detected in China...

XTIO2 Self-Cleaning Global Travel Facemask with Record Year of Orders Features at the RAND Luxury Technology Event

International Self-Powered Building Council (ISPBC) showcased its world-exclusive self-cleaning XTIO2 GLOBAL Travel Facemask for travelers with the world’s highest protection: 1...

Novavax Reports Fourth-Quarter and Year-End 2013 Financial Results and Initiation of Phase 1/2 Clinical Trial of Its H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM)

GAITHERSBURG, Md., March 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinan...

New TNO Triskelion Lab Tests Vaccines Against Deadly Viruses

ZEIST, The Netherlands, March 3, 2014 /PRNewswire/ -- Upgrade to BSL-3 level answers growing global demand for testing facilities Introduction of a Bio Safety Level 3 (BSL-3) facility and developmen...

Events [0 Results]

None

Companies [0 Results]

None

Clinical Trials [0 Results]

None

PubMed Articles [70 Associated PubMed Articles listed on BioPortfolio]

Rapid Production of Synthetic Influenza Vaccines.

The strain composition of influenza vaccines must be changed regularly to track influenza virus antigenic evolution. During outbreaks with pandemic potential, strain changes are urgent. The systems fo...

Mammalian Models for the Study of H7 Virus Pathogenesis and Transmission.

Mammalian models, most notably the mouse and ferret, have been instrumental in the assessment of avian influenza virus pathogenicity and transmissibility, and have been used widely to characterize the...

Cross-protective efficacy of Baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.

The outbreak of human infections with avian-origin H7N9 influenza has raised global concerns about a potential human pandemic. Therefore, the generation of simple and reliable newer vaccines is high p...

Early Public Response to Influenza A(H7N9) Virus, Guangzhou, China, May 30-June 7, 2013.

Genotype Diversity of H9N2 Viruses Isolated from Wild Birds and Chickens in Hunan Province, China.

Three H9N2 avian influenza viruses were isolated from the Dongting Lake wetland, among which one was from fresh egret feces, the other two were from chicken cloacal swabs in poultry markets. Phylogene...

Dear prudence.

Article highlight based on "Th2-type inflammation under conditions of pre-existing chronic disease is associated with liver damage in patients with avian influenza H7N9 virus" by Jiankang Han et al.

The R292 K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A/Shanghai/1/2013 (H7N9) influenza virus in ferrets.

 The neuraminidase (NA) inhibitors are the only licensed therapeutic option for human zoonotic H7N9 infections. An NA-R292 K mutation that confers broad-spectrum resistance to NA inhibitors has been...

Clinical and epidemiological analysis of the first case of human infection with avian influenza A (H7N9) virus in Shenzhen, China.

The novel influenza A (H7N9) virus can cause severe illness, including pneumonia and adult respiratory disorder syndrome [Au?1] (ARDS), with high rates of intensive care unit admission and death. We r...

Response of Mice and Ferrets to a Monovalent Influenza A (H7N9) Split Vaccine.

In early spring 2013, the emergence of the influenza A (H7N9) virus in humans in Eastern China raised concerns of a new influenza pandemic. Development of a safe and effective H7N9 influenza vaccine i...

A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.

The H7N9 influenza virus caused significant mortality and morbidity in infected humans during an outbreak in China in 2013 stimulating vaccine development efforts. As previous H7-based vaccines have b...

Medical and Biotech [MESH] Definitions

None available.

Search BioPortfolio:
Advertisement

Relevant Topic

Public Health
Latest News Clinical Trials Research Drugs Reports Corporate
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The mains areas of public health are epidemiology, biostatistics...

Advertisement
review and buy H7N9 Bird Flu Virus market research data and corporate reports here

Channels Quicklinks